Cipla announced the resignation of its Vice Chairman and Non-Executive Director, MK Hamied due to age and health reasons, effective from October 29, 2024. Hamied’s resignation will come into effect from the close of business hours on October 29, 2024.
MK Hamied son’s Kamil Hamied joins the board as Non-Executive Director, w.e.f. 1st November 2024.
In his previous stint at Cipla, Kamil was the Chief Strategy Officer and a member of the management team. He was involved in leading company transformation, M&A strategy, implementing a leadership structure, and more.
Kamil Hamied is an alumnus of United World College and New York University. Kamil is a seasoned entrepreneur with extensive experience in the pharmaceutical industry and wider healthcare sectors. He has successfully navigated business across Asia, Europe, and the US. During his entrepreneurial journey, Kamil also ventured into the investment realm, establishing an investment platform focused on the broader life sciences, biotechnology, genomics, AI drug development, diagnostics, etc.
The Board has also approved the appointment of Adil Zainulbhai and Abhijit Joshi as Additional Directors (Non- Executive) of the company with effect from 3rd September 2024.
Adil Zainulbhai is a Mechanical Engineering graduate from the Indian Institute of Technology and an MBA from Harvard Business School. Zainulbhai retired as Chairman of McKinsey, India after a distinguished 34-year career with the firm, including leadership roles in its Washington and Minneapolis offices. His influence extends beyond McKinsey, serving as Chairman of the Quality Council of India and as a Board Advisor to the US-India Strategic Partnership Forum.
He has been a director on the boards of prominent corporates in India like Larsen and Tourbo, Reliance Industries, etc., and is the Chairman on the Boards of Network 18 Media and Investments Limited and TV18 Broadcast Limited. He has also been on the international advisory boards of various international organisations and a member of various high-powered economic groups, advisory committees, and task-forces of the Government of India.
Abhijit Joshi is the Founding and Managing Partner of a leading law firm M/s Veritas Legal, in India and has over 35 years of experience and expertise in the fields of corporate and commercial law, merger & acquisition, risk management, litigation management, etc. He is a distinguished dual-qualified solicitor in both India and England. With a legal career spanning over three decades, he is recognized as one of Asia’s Top 15 M&A and Private Wealth Lawyers.
Joshi has advised numerous business houses and promoter families, representing global conglomerates and large private equity firms in a wide range of complex deals and cases across various industry sectors, including the pharmaceutical industry. Joshi also possesses skills in global economics, financials, risk management, strategic planning, corporate governance etc. His skills and expertise have earned him several accolades, including the Financial Times Innovation Award (Asia Pacific).
Cipla also appointed as the appointment of Sharmila Paranjpe as an Independent Director for a period of five years w.e.f. 1st September 2024; and Maya Hari as an Independent Director for a period of five years w.e.f. 1st November 2024.
